Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Astal Laboratories's share price for the quarter that ended in Mar. 2026 was ₹65.36. Astal Laboratories's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 42 Mil. Therefore, Astal Laboratories's market cap for the quarter that ended in Mar. 2026 was ₹2,759 Mil.
Astal Laboratories's quarterly market cap
increased
from Sep. 2025 (₹893 Mil) to Dec. 2025 (₹935 Mil) and
increased
from Dec. 2025 (₹935 Mil) to Mar. 2026 (₹2,759 Mil).
Astal Laboratories's annual market cap
increased
from Mar. 2024 (₹402 Mil) to Mar. 2025 (₹747 Mil) and
increased
from Mar. 2025 (₹747 Mil) to Mar. 2026 (₹2,759 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Astal Laboratories's Enterprise Value for Today is ₹4,099 Mil.
Astal Laboratories (BOM:512600) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Astal Laboratories Market Cap Related Terms
Astal Laboratories Market Cap Historical Data
* Premium members only.
The historical data trend for Astal Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Astal Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astal Laboratories Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Astal Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Astal Laboratories's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Astal Laboratories's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astal Laboratories (BOM:512600) has a Market Cap of ₹3,616 Mil as of Jul. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Astal Laboratories and its competitors. According to the industry distribution chart, Astal Laboratories ranks #741 out of 1023 companies in the Drug Manufacturers industry, placing it in the top 72.4%.
Is Astal Laboratories' Market Cap too high?
Astal Laboratories' current Market Cap is ₹3,616 Mil. Based on the distribution chart, Astal Laboratories ranks #741 out of 1023 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Astal Laboratories has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Astal Laboratories' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Astal Laboratories ranks #741 out of 1023 companies for Market Cap. This places Astal Laboratories in the lower half of its industry. The industry median Market Cap is 213.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.63, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Astal Laboratories and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astal Laboratories's current Market Cap is ₹3,616 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astal Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Astal Laboratories (BOM:512600) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹52.99, compared to a current price of ₹82.55 — trading 55.8% above its estimated fair value. The current Market Cap is ₹3,616 Mil. Astal Laboratories' overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Astal Laboratories (BOM:512600), the current Market Cap is ₹3,616 Mil as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astal Laboratories (BOM:512600) Overvalued in 2026?
Based on GuruFocus' analysis, Astal Laboratories stock appears to be overvalued.
The current stock price of ₹82.55 is trading 55.8% above its estimated GF Value™ of ₹52.99.
GuruFocus considers Astal Laboratories to be Significantly Overvalued.
Key valuation signals for BOM:512600:
Market Cap: ₹3,616 Mil
GF Value™: ₹52.99 vs. price of ₹82.55 (55.8% above fair value)
No single metric tells the full story. See the BOM:512600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astal Laboratories Ltd is an India-based company. The main objects of the company are to manufacture and sales of Pharmaceutical Intermediates and Bulk Drugs. The company has a single segment, i.e., Pharmaceuticals.
48GF Score
Get the complete analysis for BOM:512600
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512600 has been successfully added to your 
